Takeda awards RSUs to Chief Data & Tech Officer

Ricci Gabriele reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ricci Gabriele reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical’s Chief Data & Technology Officer Gabriele Ricci received an equity award of 37,616 American Depositary Shares through restricted stock units. The RSUs were granted at no cash cost and vest in three equal annual installments beginning on July 1, 2027.

Each RSU represents a contingent right to receive one American Depositary Share of Takeda Pharmaceutical Co. Ltd. Following this compensation-related grant, Ricci directly holds 196,742 American Depositary Shares, highlighting a meaningful ongoing equity stake aligned with the company’s long-term performance.

Insider Trade Summary

Grant/Award: 37,616 shares

Grant/Award 1 txn

Insider Ricci Gabriele

Role Chief Data & Tech. Officer

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	37,616	$0.00	$0.00

Holdings After Transaction: American Depositary Shares — 196,742 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSU award size: 37,616 American Depositary Shares Post-grant holdings: 196,742 American Depositary Shares Vesting schedule: Three equal annual installments +1 more

4 metrics

RSU award size 37,616 American Depositary Shares Grant of restricted stock units to Chief Data & Technology Officer

Post-grant holdings 196,742 American Depositary Shares Direct ownership after RSU award

Vesting schedule Three equal annual installments RSUs vest annually beginning July 1, 2027

Grant price per share $0.0000 per American Depositary Share Equity award granted at no cash cost to insider

Key Terms

restricted stock units (RSUs), American Depositary Shares, vesting, grant/award acquisition

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vesting financial

"The RSUs vest in three equal annual installments beginning on July 1, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Takeda (TAK) report for Gabriele Ricci?

Takeda reported that Chief Data & Technology Officer Gabriele Ricci received an award of 37,616 restricted stock units. Each unit corresponds to one American Depositary Share, increasing his direct Takeda equity holdings as part of his compensation package.

How many Takeda (TAK) shares does Gabriele Ricci hold after this Form 4?

After the reported award, Gabriele Ricci directly holds 196,742 American Depositary Shares of Takeda. This figure includes the new 37,616 restricted stock units, which are structured to vest over time, aligning his compensation with long-term company performance.

What are the vesting terms of Gabriele Ricci’s new Takeda (TAK) RSUs?

The granted restricted stock units vest in three equal annual installments starting on July 1, 2027. This schedule spreads the award over three years, encouraging longer-term retention and alignment between Ricci’s incentives and Takeda Pharmaceutical’s future results.

Did Gabriele Ricci buy Takeda (TAK) shares on the open market?

No, the filing shows a grant of restricted stock units rather than an open-market purchase. The 37,616 American Depositary Shares were awarded at no cash cost as equity compensation, coded as a grant or other acquisition on the Form 4.

What does each Takeda (TAK) restricted stock unit represent in this Form 4?

Each restricted stock unit represents a contingent right to receive one American Depositary Share of Takeda. The units convert into actual ADSs as they vest according to the three-year schedule beginning July 1, 2027, subject to continued service and award terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ricci Gabriele

(Last) (First) (Middle)

650 E. KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Data & Tech. Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		37,616	A	$0	196,742	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Gabriele Ricci	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)